EAM
Eventide Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-209,794
| Closed | -$8.05M | – | 181 |
|
|
2024
Q2 | $8.05M | Hold |
209,794
| – | – | 0.14% | 129 |
|
|
2024
Q1 | $12.3M | Hold |
209,794
| – | – | 0.19% | 113 |
|
|
2023
Q4 | $12.6M | Buy |
+209,794
| New | +$12.6M | 0.21% | 112 |
|
|
2023
Q3 | – | Sell |
-397,141
| Closed | -$36.2M | – | 157 |
|
|
2023
Q2 | $36.2M | Sell |
397,141
-97,859
| -20% | -$8.91M | 0.61% | 53 |
|
|
2023
Q1 | $32.7M | Buy |
495,000
+155,645
| +46% | +$10.3M | 0.6% | 57 |
|
|
2022
Q4 | $17.5M | Hold |
339,355
| – | – | 0.35% | 82 |
|
|
2022
Q3 | $23.2M | Buy |
+339,355
| New | +$23.2M | 0.46% | 68 |
|